ABVD chemotherapy without obligatory radiotherapy in patients with early and intermediate stage Hodgkin' lymphoma.

被引：0
|
作者：
Naumann, R
Haenel, A
Kroschinsky, F
Beuthien-Baumann, B
Dawel, M
Zschuppe, E
Schmidt, H
Fiedler, F
Ehninger, G
Haenel, M
机构：
[1] Univ Hosp, Dept Internal Med, Dresden, Germany
[2] Kuechwald Hosp, Dept Internal Med, Chemnitz, Germany
[3] Univ Hosp, PET Ctr, Dept Nucl Med, Dresden, Germany
[4] Univ Hosp, Dept Radiotherapy, Dresden, Germany
[5] Friedrichstadt Hosp, Dept Internal Med, Dresden, Germany
[6] Hameln Hosp, Dept Internal Med, Hameln, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4749
引用
收藏
页码：302B / 302B
页数：1
相关论文
共 50 条
  • [31] ABVD vs. radiotherapy in early stage Hodgkin's lymphoma A critical look at the NCIC HD.6 trial
    Wenz, F.
    Abo-Madyan, Y.
    Welzel, G.
    Giordano, F. A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (08) : 649 - 652
  • [32] Intermediate stage Hodgkin's disease:: Preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy
    Anselmo, AP
    Cavalieri, E
    Osti, FM
    Cantonetti, M
    De Sanctis, V
    Alfo, M
    Amadori, S
    Enrici, RM
    ANTICANCER RESEARCH, 2004, 24 (06) : 4045 - 4050
  • [33] Patient Outcomes with and Without Radiotherapy for Early Stage Hodgkin Lymphoma in the Post-PET Era
    McLaughlin, C.
    Slade, A. N.
    Mukhopadhyay, N. D.
    Song, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E477 - E477
  • [34] Increased Relapse Rates in Early Stage Hodgkin Lymphoma (HL) Patients without Radiotherapy: The German Society of Radiooncology (DEGRO) Advises to Treat all Early Stage HL Patients with Radiotherapy
    Koerholz, D.
    Mauz-Koerholz, C.
    Vordermark, D.
    Kluge, R.
    Dieckmann, K.
    KLINISCHE PADIATRIE, 2014, 226 (6-7): : 307 - 308
  • [35] Consolidative Radiation Therapy for Stage III Hodgkin Lymphoma in Patients Who Achieve Complete Response After ABVD Chemotherapy
    Phan, Jack
    Mazloom, Ali
    Abboud, Mirna
    Salehpour, Mohammad
    Reed, Valerie
    Zreik, Tony
    Shihadeh, Ferial
    Fisher, Christine
    Wogan, Christine
    Dabaja, Bouthaina
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 499 - 505
  • [36] ABVD chemotherapy is essential for optimal treatment of limited stage nodular lymphocyte predominant Hodgkin lymphoma
    Savage, K. J.
    Hoskins, P.
    Klasa, R.
    Sehn, L. H.
    Shenkier, T.
    Voss, N.
    Gascoyne, R. D.
    SKinnider, B.
    Connors, J. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 27 - 28
  • [37] Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation
    Gunther, J. R.
    Fanale, M.
    Reddy, J.
    Akhtari, M.
    Smith, G. L.
    Pinnix, C. C.
    Milgrom, S. A.
    Abou Yehia, Z.
    Osborne, E. M.
    Mawlawi, O. R.
    Allen, P. K.
    Dabaja, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S21 - S22
  • [38] ABVD WITH OR WITHOUT RADIOTHERAPY IN THE TREATMENT OF ADVANCED STAGE HODGKIN DISEASE. ONE CENTER EXPERIENCE
    Manaka, A.
    Panitsas, F.
    Tzannou, I
    Vourtsi, A.
    Balta, A.
    Oikonomopoulos, P.
    Komitopoulou, A.
    Skertsou, M.
    Kourti, G.
    Gigantes, S.
    Pagoni, M.
    Apostolidis, J.
    Baltadakis, G.
    Delibasi, S.
    Karakasis, D.
    Karmiris, T.
    Bakiri, M.
    Harhalakis, N.
    HAEMATOLOGICA, 2010, 95 : S20 - S20
  • [39] The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy
    Savage, K. J.
    Connors, J. M.
    Klasa, R. J.
    Hoskins, P.
    Shenkier, T. N.
    Gascoyne, R. D.
    Bhimji, S.
    Pickles, T.
    Benard, F.
    Wilson, D.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Concurrent chemotherapy and radiotherapy (CRT) in relapsed or refractory non-Hodgkin's lymphoma.
    Lapusan, S
    Ribrag, V
    Driss, B
    Vantelon, SM
    Fermé, C
    Bourhis, JH
    Girinsky, T
    BLOOD, 2001, 98 (11) : 243B - 244B
12345